Interventional Oncology Devices Market Developments and Growth Opportunities Across 2026–2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Interventional Oncology Devices Market Between 2026 And 2030?
The interventional oncology devices market has experienced robust expansion in recent years. Its size is projected to increase from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The growth observed historically can be linked to several factors, including rising cancer incidence rates, the expansion of interventional radiology practices, continuous improvements in imaging technologies, the increasing adoption of minimally invasive oncology treatments, and the availability of specialized oncology centers.
The interventional oncology devices market is projected to experience substantial expansion in the coming years. Its size is anticipated to reach $3.5 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This growth over the forecast period is attributable to several factors, including heightened demand for targeted cancer treatments, increased investments in precision oncology, the widening availability of outpatient cancer treatment facilities, the growing acceptance of combination interventional therapies, and breakthroughs in ablation and embolization device technology. Key trends anticipated during this period encompass the greater embrace of image-guided tumor ablation devices, an increase in minimally invasive cancer treatment applications, the expanding use of embolization therapies, a rise in precision oncology procedures, and improved incorporation of advanced imaging support systems.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
What Key Drivers Are Influencing The Growth Of The Interventional Oncology Devices Market?
The widespread occurrence of cancer is anticipated to propel the growth of the interventional oncology devices market moving forward. Cancer refers to a group of illnesses characterized by the uncontrolled multiplication and dissemination of abnormal cells within the body. These atypical cells can form masses or tumors. The substantial prevalence of cancer drives up the demand for interventional oncology devices, as these instruments are utilized in the diagnosis, treatment, and management of cancer, assisting with early detection, staging, and monitoring. For instance, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in Australia, the count of diagnosed cancer cases rose from 160,570 in 2022 to 164,694 in 2023, demonstrating a significant increase over the year. This upward trajectory emphasizes the expanding prevalence of cancer within the country. Therefore, the significant prevalence of cancer is a primary driver for the growth of the interventional oncology devices market.
Which Market Segments Are Examined In The Interventional Oncology Devices Market Study?
The interventional oncology devices market covered in this report is segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems
Which Trends Are Influencing The Interventional Oncology Devices Market?
Leading companies in the interventional oncology devices market are concentrating on technologies like tissue volume to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume denotes the quantity of biological tissue acquired during a biopsy. Greater tissue volumes yield more comprehensive samples, which enhances diagnostic accuracy and optimizes treatment planning. For example, in June 2023, Argon Medical, a US-based medical device firm, unveiled the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage is designed to collect up to 35% more samples than prominent competitors, thereby reducing the requirement for multiple passes during biopsies. This attribute is essential for securing adequate tissue samples necessary for accurate diagnosis.
Who Are The Primary Competitors In The Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation
Read the full interventional oncology devices market report here:
Which Region Is Expected To Register The Fastest Growth In The Interventional Oncology Devices Market?
North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Interventional Oncology Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp
Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company
Cardiovascular Surgery Devices And Equipment Market Report 2026
Cardiac Assist Devices And Equipment Market Report 2026
Cardiovascular Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
